Idenix Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
December 05 2012 - 3:05PM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that
Idenix management will present a corporate overview at the
Oppenheimer 23rd Annual Healthcare Conference on Wednesday,
December 12th, 2012 at 2:45 p.m. ET at the Waldorf Astoria, New
York City.
The live and archived webcast of the company presentation can be
accessed under "Events & Presentations" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived replay
will be available on the Idenix website for two weeks following the
conference.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of patients
with hepatitis C infection. For further information about Idenix,
please refer to http://www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals News Articles